Joseph P. Hagan
2021 - Regulus Therapeutics
In 2021, Joseph P. Hagan earned a total compensation of $1.8M as President & Chief Executive Officer at Regulus Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $289,425 |
|---|---|
| Option Awards | $954,000 |
| Salary | $567,500 |
| Other | $11,322 |
| Total | $1,822,247 |
Hagan received $954K in option awards, accounting for 52% of the total pay in 2021.
Hagan also received $289.4K in non-equity incentive plan, $567.5K in salary and $11.3K in other compensation.
Rankings
In 2021, Joseph P. Hagan's compensation ranked 6,401st out of 12,415 executives tracked by ExecPay. In other words, Hagan earned more than 48.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,401 out of 12,415 | 48th |
Division Manufacturing | 2,734 out of 5,508 | 50th |
Major group Chemicals And Allied Products | 1,207 out of 2,378 | 49th |
Industry group Drugs | 1,075 out of 2,099 | 49th |
Industry Pharmaceutical Preparations | 777 out of 1,549 | 50th |
Source: SEC filing on April 27, 2022.
Hagan's colleagues
We found two more compensation records of executives who worked with Joseph P. Hagan at Regulus Therapeutics in 2021.
News
Regulus Therapeutics CEO Joseph Hagan's 2021 pay falls 22% to $1.8M
April 27, 2022
Regulus Therapeutics CEO Joseph Hagan's 2020 pay rises 16% to $2.3M
April 30, 2021
Regulus Therapeutics CEO Joseph Hagan's 2019 pay slips 14% to $2M
April 29, 2020
Regulus Therapeutics CEO Joseph Hagan's 2018 pay jumps 22% to $2.3M
July 1, 2019